Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody persistence after pentavalent vs hexavalent childhood vaccines in Thai children
TCTR20231017001Phase 4Unknown
- Sponsor
- National Research Council of Thailand
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 4 trial in diphtheria, Tetanus, pertussis and 4 more, sponsored by National Research Council of Thailand. Primary endpoint: Serum antibody persistence to vaccine antigens. Status: unknown.
02
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)measles
Beyond the preview
Go deeper on TCTR20231017001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231017001.